enzalutamide
pfizer,astellas
['5069', 'prostate', 'arches', 'pfizer']
at #asco22, see a post hoc analysis of arches assessing clinical outcomes &amp; safety by age subgroups &lt;75 yrs or 75+ yrs in patients w/ metastatic hormone-sensitive #prostatecancer receiving an androgen receptor inhibitor + adt or placebo + adt 5069 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ